Terms: = Pancreatic cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1
232 results:
1. Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/vegfr Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors.
Hu Y; Narayan A; Xu Y; Wolfe J; Vu D; Trinh T; Kantak C; Ivy SP; Eder JP; Deng Y; LoRusso P; Kim JW; Patel AA
JCO Precis Oncol; 2024 Feb; 8():e2300289. PubMed ID: 38412387
[TBL] [Abstract] [Full Text] [Related]
2. Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells.
Kaçaroğlu D; Yaylacı S; Gurbuz N
Cancer Med; 2024 Jan; 13(2):e6964. PubMed ID: 38379331
[TBL] [Abstract] [Full Text] [Related]
3. Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration.
Liu A; Gammon ST; Pisaneschi F; Boda A; Ager CR; Piwnica-Worms D; Hong DS; Curran MA
JCI Insight; 2024 Jan; 9(1):. PubMed ID: 37988164
[TBL] [Abstract] [Full Text] [Related]
4. Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving pancreatic cancer Angiosuppression.
Hasselluhn MC; Decker-Farrell AR; Vlahos L; Thomas DH; Curiel-Garcia A; Maurer HC; Wasko UN; Tomassoni L; Sastra SA; Palermo CF; Dalton TC; Ma A; Li F; Tolosa EJ; Hibshoosh H; Fernandez-Zapico ME; Muir A; Califano A; Olive KP
Cancer Discov; 2024 Feb; 14(2):348-361. PubMed ID: 37966260
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
6. A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis.
Song N; Tang Y; Wang Y; Guan X; Yu W; Jiang T; Lu L; Gu Y
Mar Drugs; 2023 Sep; 21(10):. PubMed ID: 37888452
[TBL] [Abstract] [Full Text] [Related]
7. Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S
BMC Cancer; 2023 Sep; 23(1):908. PubMed ID: 37752423
[TBL] [Abstract] [Full Text] [Related]
8. [Apatinib Suppressed Macrophage-Mediated Malignant Behavior of Hepatocellular Carcinoma Cells via Modulation of vegfr2/STAT3/PD-L1 Signaling].
Yin T; Fu CB; Wu DD; Nie L; Chen H; Wang Y
Mol Biol (Mosk); 2023; 57(4):706-708. PubMed ID: 37528791
[TBL] [Abstract] [Full Text] [Related]
9. vegfr2 targeted microbubble-based ultrasound molecular imaging improving the diagnostic sensitivity of microinvasive cervical cancer.
Zhong J; Su M; Jiang Y; Huang L; Chen Y; Huang Z; Zhang X
J Nanobiotechnology; 2023 Jul; 21(1):220. PubMed ID: 37438780
[TBL] [Abstract] [Full Text] [Related]
10. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
Lu G; Wang X; Cheng M; Wang S; Ma K
Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
[TBL] [Abstract] [Full Text] [Related]
11. Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).
Shaib WL; Manali R; Liu Y; El-Rayes B; Loehrer P; O'Neil B; Cohen S; Khair T; Robin E; Huyck T; Bekaii-Saab T
Eur J Cancer; 2023 Aug; 189():112847. PubMed ID: 37268519
[TBL] [Abstract] [Full Text] [Related]
12. Design, Synthesis and Biological Evaluation of Novel Catalpol Derivatives as Potential pancreatic cancer Inhibitors.
Kong Y; Liu S; Wang S; Xu J; Hu Y; Jiang S; Dong C
Chem Asian J; 2023 Jun; 18(12):e202300185. PubMed ID: 37129956
[TBL] [Abstract] [Full Text] [Related]
13. A dose escalation/expansion study evaluating dose, safety, and efficacy of the novel tyrosine kinase inhibitor surufatinib, which inhibits vegfr 1, 2, & 3, FGFR 1, and CSF1R, in US patients with neuroendocrine tumors.
Dasari A; Hamilton EP; Falchook GS; Wang JS; Li D; Sung MW; Chien C; Nanda S; Tucci C; Hahka-Kemppinen M; Paulson AS
Invest New Drugs; 2023 Jun; 41(3):421-430. PubMed ID: 37074571
[TBL] [Abstract] [Full Text] [Related]
14. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract] [Full Text] [Related]
15. Synthesis of Palladium-Catalysed C-C Bond Forming 5-Chloro Quinolines via Suzuki-Miyaura Coupling; Anti-pancreatic cancer Screening on PANC-1 Cell Lines.
Rahman A; Ningegowda NB; Siddappa MK; Pargi M; Kumaraswamy HM; Satyanarayan ND; Achur R
Chem Biodivers; 2023 Jan; 20(1):e202200622. PubMed ID: 36437502
[TBL] [Abstract] [Full Text] [Related]
16. Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature review.
Wang Y; Wang B; Xiang L; Deng J; Xu B; He P; Pu W; Wang H; Fan Y; Chen H
Front Immunol; 2022; 13():1016647. PubMed ID: 36311715
[TBL] [Abstract] [Full Text] [Related]
17. Maximum Value on Arterial Phase Computed Tomography Predicts Prognosis and Treatment Efficacy of Sunitinib for pancreatic Neuroendocrine Tumours.
Chen H; Li Z; Hu Y; Xu X; Ye Z; Lou X; Zhang W; Gao H; Qin Y; Zhang Y; Chen X; Chen J; Tang W; Yu X; Ji S
Ann Surg Oncol; 2023 May; 30(5):2988-2998. PubMed ID: 36310316
[TBL] [Abstract] [Full Text] [Related]
18. The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis.
Muraishi N; Kawamura Y; Akuta N; Shindoh J; Matsumura M; Okubo S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Yasuda I; Kumada H
Oncology; 2023; 101(2):134-144. PubMed ID: 36103864
[TBL] [Abstract] [Full Text] [Related]
19. Antipsychotic drugs induce vascular defects in hematopoietic organs.
Deng ZH; Zhong J; Jiang HL; Jeong HW; Chen JW; Shu YH; Tan M; Adams RH; Xie KP; Chen Q; Liu Y
FASEB J; 2022 Oct; 36(10):e22538. PubMed ID: 36065631
[TBL] [Abstract] [Full Text] [Related]
20. Peripancreatic paraganglioma: Lesson from a round table.
Petrelli F; Fratini G; Sbrozzi-Vanni A; Giusti A; Manta R; Vignali C; Nesi G; Amorosi A; Cavazzana A; Arganini M; Ambrosio MR
World J Gastroenterol; 2022 Jun; 28(21):2396-2402. PubMed ID: 35800185
[TBL] [Abstract] [Full Text] [Related]
[Next]
